Evidence map›Paper›PMID 32102991›Full record

ArticleCell death & disease2020

Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.

Josephine Volovetz, Artem D Berezovsky, Tyler Alban, Yujun Chen, Adam Lauko, George F Aranjuez, Ashley Burtscher, Kelly Shibuya, Daniel J Silver, John Peterson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Frontiers in cell and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. C3G Protein, a New Player in Glioblastoma.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Josephine Volovetz *Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Artem D Berezovsky *Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Tyler Alban *Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Yujun ChenDivision of Biology, Kansas State University, Manhattan, KS, 66506, USA.
Adam LaukoLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
George F AranjuezLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Ashley BurtscherLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Kelly ShibuyaLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Daniel J SilverLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
John PetersonLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Danny ManorDepartment of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
Jocelyn A McDonaldLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. jmcdona@ksu.edu.ORCID http://orcid.org/0000-0002-7494-1466
Justin D LathiaLerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. lathiaj@ccf.org.ORCID http://orcid.org/0000-0003-3168-7290
Cleveland Clinic Lerner College of Medicine · USKansas State University · USUniversity of Central Florida · USUniversity School · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
RESEARCH ONCOLOGY TRAINING GRANTT32CA059366 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JACKSON, MARK W. · 1993 to 2025
$5.5M
Spinning Disk Confocoal MicroscopeS10RR026820 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2010 to 2010
$500k
Consequence of collective cell invasion in glioblastomaR21CA198254 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LATHIA, JUSTIN D., MCDONALD, JOCELYN A · 2015 to 2016
$379k
NCI NIH HHS R21 CA198254NCI NIH HHS T32 CA059366NCRR NIH HHS S10 RR026820NIGMS NIH HHS P20 GM103418NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most prevalent primary malignant brain tumor and is associated with extensive tumor cell infiltration into the adjacent brain parenchyma. However, there are limited targeted therapies that address this disease hallmark. While the invasive capacity of self-renewing cancer stem cells (CSCs) and their non-CSC progeny has been investigated, the mode(s) of migration used by CSCs during invasion is currently unknown. Here we used time-lapse microscopy to evaluate the migratory behavior of CSCs, with a focus on identifying key regulators of migration. A head-to-head migration assay demonstrated that CSCs are more invasive than non-CSCs. Time-lapse live cell imaging further revealed that GBM patient-derived CSC models either migrate in a collective manner or in a single cell fashion. To uncover conserved molecular regulators responsible for collective cell invasion, we utilized the genetically tractable Drosophila border cell collective migration model. Candidates for functional studies were generated using results from a targeted Drosophila genetic screen followed by gene expression analysis of the human homologs in GBM tumors and associated GBM patient prognosis. This strategy identified the highly conserved small GTPase, Rap1a, as a potential regulator of cell invasion. Alteration of Rap1a activity impaired the forward progress of Drosophila border cells during development. Rap1a expression was elevated in GBM and associated with higher tumor grade. Functionally, the levels of activated Rap1a impacted CSC migration speed out of spheres onto extracellular matrix. The data presented here demonstrate that CSCs are more invasive than non-CSCs, are capable of both collective and single cell migration, and express conserved genes that are required for migration and invasion. Using this integrated approach, we identified a new role for Rap1a in the migration of GBM CSCs.

Indexed as

Brain NeoplasmsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticGlioblastomaHumansNeoplastic Stem CellsPrognosis

Identifiers

PMID32102991
PMCPMC7044427
OpenAlexW3008228447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.